First Aid Triple Antibiotic with Pain Reliever Interactions
There are 68 drugs known to interact with First Aid Triple Antibiotic with Pain Reliever (bacitracin / lidocaine / neomycin / polymyxin b topical), along with 7 disease interactions. Of the total drug interactions, 2 are major, and 66 are moderate.
- View all 68 medications that may interact with First Aid Triple Antibiotic with Pain Reliever
- View First Aid Triple Antibiotic with Pain Reliever disease interactions (7)
Most frequently checked interactions
View interaction reports for First Aid Triple Antibiotic with Pain Reliever (bacitracin / lidocaine / neomycin / polymyxin b topical) and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- acetaminophen
- Adderall XR (amphetamine / dextroamphetamine)
- Airborne (multivitamin with minerals)
- albuterol
- Alcohol (contained in alcoholic beverages) (ethanol)
- alprazolam
- amlodipine
- amoxicillin
- amphetamine / dextroamphetamine
- Armour Thyroid (thyroid desiccated)
- aspirin
- Aspirin Low Strength (aspirin)
- Athlete's Foot Antifungal Liquid (tolnaftate topical)
- Azo Urinary Pain Relief (phenazopyridine)
- baical skullcap
- Banophen Anti Itch (diphenhydramine / zinc acetate topical)
- Benadryl (diphenhydramine)
- bismuth subsalicylate
- caffeine
- Caladryl Clear (pramoxine/zinc acetate topical)
- cefdinir
- cephalexin
- cetirizine
- chlorpheniramine / dextromethorphan
- cholecalciferol
- clobetasol topical
- ibuprofen
- ketoconazole topical
- losartan
First Aid Triple Antibiotic with Pain Reliever disease interactions
There are 7 disease interactions with First Aid Triple Antibiotic with Pain Reliever (bacitracin / lidocaine / neomycin / polymyxin b topical) which include:
- teething pain
- cardiovascular dysfunction
- hepatic dysfunction
- renal dysfunction
- seizures
- perforated tympanic membrane
- burns
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.